You say that Fred but on the recently continued Keytruda trial HALO is still having to administer anti clotting LMW Heparin (albeit at lower doses) to potentially bleeding patients so I can see this being halted again like on the Cinryse trial. At the present time HALO seems to be staggering around from one potential disaster to another and in the meantime there is no good news on new partnerships or other partnered programs or on PEG related issues.